insights_auto
Why is ARX down 5,71%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,50 A$
arrow_downward
-5,71%(-0,030) 1D
1 қаз., 12:56:23 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 A$
High
0,50 A$
Low
0,49 A$
Mkt. cap
171,22 млн
Avg. vol.
138,96 м.
Volume
112,71 м.
P/E ratio
47,64
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 млн
No. of employees
261
Open
0,50 A$
High
0,50 A$
Low
0,49 A$
Mkt. cap
171,22 млн
Avg. vol.
138,96 м.
Volume
112,71 м.
P/E ratio
47,64
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 млн
No. of employees
261
News stories
From web sources and news partners
Simply Wall Street
·
21 минут бұрын
Is NetApp (NTAP) Becoming More Central To AI Infrastructure With Novus?
Kalkine Media
·
1 сағат бұрын
BVF Partners Reveals 5.6% Ownership Stake in Stoke Therapeutics Inc. (NASDAQ:STOK)
Barchart.com
·
1 сағат бұрын
What You Need To Know Ahead of Nasdaq's Earnings Release
Yahoo Finance
·
6 сағат бұрын
Blood Cancer United Rings Nasdaq Closing Bell to Celebrate More Time for Patients
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd